HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Renaissance

This article was originally published in The Rose Sheet

Executive Summary

Receiving up to $2 mil. in new debt financing from holders of the company's 11-3/4% senior notes to "address immediate working capital needs," the firm announced Aug. 27. Renaissance Cosmetics is also implementing a financial restructuring through a prenegotiated Chapter 11 plan. Renaissance will convert $200 mil. in outstanding senior notes and accrued and unpaid interest into 100% of the company's common stock. All of Renaissance's outstanding preferred and common stock will be canceled, and holders of those shares will receive stock in the reorganized company. Renaissance said it "does not foresee a bankruptcy filing." The company reported a net loss of $19.2 mil. on sales of $41 mil. for the first quarter of fiscal 1998 (ended June 30). Roughly $4 mil. of the loss was related to Renaissance's operational restructuring in February...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005752

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel